Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Semprex®-D Capsules (acrivastine and pseudoephedrine hydrochloride)
Medication labelWhy this: Advisory · dailymed-prescription
SEMPREX-D Capsules are indicated for relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. SEMPREX-D Capsules should be administered when both the antihistaminic activity of acrivastine and the nasal decongestant activity of pseudoephedrine are desired (see CLINICAL PHARMACOLOGY). The efficacy of SEMPREX-D Capsules beyond 14 days of continuous treatment in patients with seasonal allergic rhinitis has not been adequately investigated in clinical trials. SEMPREX-D Capsules have not been adequately studied for effectiveness in relieving the symptoms of the common cold.
- generic_name
- acrivastine and pseudoephedrine hydrochloride
- brand_name
- Semprex-D, acrivastine, pseudoephedrine hydrochloride, pseudoephedrine
- product_names
- acrivastine and pseudoephedrine hydrochloride, Semprex-D, acrivastine, pseudoephedrine hydrochloride, pseudoephedrine
- ndc
- 53014-404, 53014-404-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en